The substantial data supporting platelet-rich plasma (PRP) therapy and exosomes for androgenic alopecia have yet to convince ...

Stem cell therapy aims to reboot the immune system and prevent MS attacks. Though it shows promise and is available through clinical trials, it’s not FDA-approved to treat MS. If you’re ...

Three Georgia companies and their principals have been banned from continuing their "bogus claims" that their stem cell ...

Allogeneic stem cell therapy allows "off the shelf" cells ... Presuming that EU approval can be secured, the next major milestone will be FDA approval. In March this year the company received ...

HOUSTON, January 13, 2025--(BUSINESS WIRE)--IPS HEART has been awarded Orphan Drug Designation (ODD) by the FDA for GIVI-MPCs ... potential of pluripotent stem cell therapy. IPS HEART has also ...

Incyte and Syndax Pharmaceutical said the Food and Drug Administration approved their graft disease treatment Niktimvo antibody in nine milligram and 22 milligram vial sizes.

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...

Ips Heart Inc. has been awarded orphan drug designation by the FDA for its GIVI-MPC stem cell therapy for Becker muscular dystrophy. GIVI-MPC has the unique ability to create new muscle with full ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...